Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis
Lone Skov, Andrew Pink, Christophe Piketty, Gil Yosipovitch et al.
Citations
2 citations
Journal
Journal of the European Academy of Dermatology and Venereology
Topics
Dermatology and Skin Diseases
Field-Weighted Citation Impact (FWCI)
4.01
article
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis
Lone Skov, Andrew Pink, Christophe Piketty, Gil Yosipovitch, Sonja Ständer, Vivian Laquer, S. Barbarot, Zarif K. Jabbar‐Lopez, Curdin Conrad, Aliene Noda, Athanasios Tsianakas, Adam Reich, Franz J. Legat, Martin Metz, Shawn G. Kwatra, Elke Weißhaar, Jacek Cezary Szepietowski, Maxwell Benjamin Sauder, Diamant Thaçi, L. Misery, Xiaoxiao Chen, Raja Sivamani, Serge Boulinguez
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of the European Academy of Dermatology and Venereology
Institutions
University of Maryland, Baltimore (US), University of Miami (US), Université Fédérale de Toulouse Midi-Pyrénées (FR), King's College London (GB), University of Toronto (CA), Guy's and St Thomas' NHS Foundation Trust (GB), Medical University of Graz (AT), Heidelberg University (DE), University Hospital Heidelberg (DE), Gentofte Hospital (DK), Orange Coast Memorial Medical Center (US), Centre Hospitalier Universitaire de Nantes (FR), University Hospital Münster (DE), Zentralklinik Bad Berka (DE), Galderma (United States) (US), Probity Medical Research (CA), Centre Hospitalier Régional Universitaire de Brest (FR), University Dermatology (US), St. Petersburg State Medical Academy "City Polyclinic №44" (RU), West Coast Fertility Centers (US), Life Medical Control (France) (FR), Galderma (Switzerland) (CH), AGH University of Krakow (PL), Charité - Universitätsmedizin Berlin (DE), University of Lübeck (DE), Nantes Université (FR), University of Lausanne (CH), University of Rzeszów (PL)
Funders
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Biogen, Teva Pharmaceutical Industries, Celgene, Regeneron Pharmaceuticals, Celldex Therapeutics, Fresenius Medical Care North America, Kiniksa Pharmaceuticals, Incyte, Argenx, Horizon Therapeutics, Galderma, InflaRx, LEO Pharma, Samsung, UCB Pharma